骨髓涂片和骨髓活检在骨髓增生异常综合征诊断中的意义  

Comparison of Bone Marrow Smears vs Bone Marrow Biopsy in Diagnosis of Myelodysplastic Syndrome

作　　者：张还珠[1] 唐继森[1] 黄雅廉[1] 何小凡[2] 

机构地区：[1]广州医学院第一附属医院血液科,广州510120 [2]广东省人民医院血液研究室,广州510080

出　　处：《现代临床医学生物工程学杂志》1997年第1期10-11,共2页Journal of Modern Clinical Medical Bioengineering

摘　　要：对33例初诊骨髓增生异常综合征病人的骨髓涂片及骨髓活检进行分析,表明涂片在初诊筛选中能对MDS作出诊断,而骨髓活检对判断增生度,显示各系病态造血,提供预后信息及确诊MDS合并骨髓纤维化中意义重大,后者对前者起补充、修正的作用.The significance of bone marrow smears and bone marrow biopsy was evaluated in diagnosis of 33 cases of myelodysplastic syndrome(MDS). The result indicated that bone marrow smears could make the diagnosis of de novo MDS, and bone marrow biopsy showed signifIcance in judging cellularity, displaying qualitative abnormalities of erythroid, myeloid and megakaryocytic maturation, providing prognostic messages and confirmign MDS complicated with myelofibrosis. The latter may amend and replenish the former.

关 键 词：诊断 骨髓活检 骨髓增生异常综合征 骨髓涂片 初诊 MDS 骨髓纤维化 显示 合并 信息 

分 类 号：R551.3[医药卫生—血液循环系统疾病] R733[医药卫生—内科学]